TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8+ T-cell subsets in lymph nodes and tumors.
George VK, Wong HC, Felices M, Rubinstein MP, Shrestha N, Valderrama N, Farzaneh H, Kong L, Gilkes C, Thompson A, Larson M, Liu B, Zhu X, Leclerc GM, Chung D, Xie J, Krull J, Gomez L, Kanakaraj L, Bialik A, Egan JO, You L, Liu X, Teodorescu R, Gutierrez AKK, Echeverri C, Rodriguez R, Wang Z, Xing J, Gonzalez N, Chaturvedi P, Patel MR, Wangen R, Cao Q, Rhode PR, Miller JS, Geller MA.
George VK, et al. Among authors: xing j.
J Immunother Cancer. 2025 Dec 21;13(12):e013533. doi: 10.1136/jitc-2025-013533.
J Immunother Cancer. 2025.
PMID: 41423270
Free PMC article.